CIRM Clinical Dashboard

Funding Clinical Trials

Our Agency funds clinical trials testing promising stem cell-based treatments for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.

CIRM Clinical Dashboard

Disease Areas Investigator Organization Phase Trial Statussort descending Targeted Enrollment Detail
  • Leukemia, Acute Myeloid (AML)
Mark Chao Forty Seven Inc. Phase 1 Active, not recruiting 258
Michael Pulsipher Children's Hospital of Los Angeles Phase 1/2 Active, not recruiting 60
Mark Humayun University of Southern California Phase 1 Active, not recruiting 16
Daniel Brennan Medeor Therapeutics, Inc. Phase 3 Active, not recruiting 30
  • Beta Thalassemia
Bettina Cockroft Sangamo BioSciences, Inc. Phase 1/2 Active, not recruiting 6
  • Immune Disease
  • Pediatrics
  • X-linked Chronic Granulomatous Disease
Donald Kohn University of California, Los Angeles Phase 1/2 Active, not recruiting 16
  • Immune Disease
  • Leukocyte Adhesion Deficiency
Kinnari Patel Rocket Pharmaceuticals, Inc. Phase 1/2 Active, not recruiting 9
John Zaia City of Hope, Beckman Research Institute Phase 1 Active, not recruiting 12
  • Pulmonary Hypertension
  • Vascular Disease
Michael Lewis Cedars-Sinai Medical Center Phase 1/2 Active, not recruiting 26
William van der Touw Celularity Inc Phase 1/2 Active, not recruiting 86
Jeffrey Lawson Humacyte, Inc. Phase 3 Active, not recruiting 355
Robert Lowsky Stanford University Phase 1 Active, not recruiting 15
David Williams Boston Children's Hospital Phase 2 Active, not recruiting 10
Christine Brown City of Hope, Beckman Research Institute Phase 1 Active, not recruiting 82
Manasi Jaiman ViaCyte, Inc. Phase 1/2 Active, not recruiting 75
  • Multiple Myeloma
Rajesh Belani Poseida Therapeutics, Inc. Phase 1 Closed 105
Rachel Smith Capricor, Inc Phase 2 Closed 156
Gayatri Rao Rocket Pharmaceuticals, Inc. Phase 1 Closed 1
Robert Dillman Caladrius Biosciences Phase 3 Closed 4
Howard Foyt ViaCyte, Inc. Phase 1/2 Closed 19
  • Leukemia, Acute Myeloid (AML)
Colleen Delaney Nohla Therapeutics Inc Phase 2 Closed 146
Vicki Wheelock University of California, Davis Phase 1/2 Completed 29
Francois Binette Lineage Cell Therapeutics Inc. Phase 1/2 Completed 25
Kristen Johnson Calibr Phase 1 Completed 60
Bijan Nejadnik SanBio, Inc. Phase 2 Completed 163
Clive Svendsen Cedars-Sinai Medical Center Phase 1/2 Completed 18
Henry Klassen University of California, Irvine Phase 1/2 Completed 28
Henry Klassen jCyte, Inc Phase 2 Completed 84
Edward Kavalerchik Angiocrine Bioscience, Inc. Phase 1 Completed 42
Donald Kohn University of California, Los Angeles Phase 2 Completed 10
Geoff Symonds Calimmune, Inc. Phase 1/2 Completed 13
Thomas Kipps University of California, San Diego Phase 1 Completed 26
Irving Weissman Stanford University Phase 1 Completed 88
Dennis Slamon University of California, Los Angeles Phase 1 Completed 48
Henry Klassen jCyte, Inc Phase 2 Completed 84
Mark Chao Forty Seven Inc. Phase 1/2 Completed 78
Nancy Lane University of California, Davis Phase 1/2 Completed 58
William Sietsema Caladrius Biosciences Phase 2 Completed 113
Linda Marban Capricor, Inc Phase 2 Completed 25
Edward Kavalerchik Angiocrine Bioscience, Inc. Phase 1 Completed 10
Ralph Kern BrainStorm Cell Therapeutics Phase 3 Completed 263
Jane Lebkowski Geron Corporation Phase 1 Completed 5
  • Alpha Thalassemia Major
Tippi MacKenzie University of California, San Francisco Phase 1 Enrolling by invitation 10
Mark Walters University of California, San Francisco Phase 1 Launching N/A
Jana Portnow City of Hope, Beckman Research Institute Phase 1 Launching N/A
John Zaia City of Hope, Beckman Research Institute Phase 1 Launching N/A
Steven Deeks University of California, San Francisco Phase 1/2 Launching N/A
Clive Svendsen Cedars-Sinai Medical Center Phase 1 Launching N/A
  • Bladder or Urinary Tract Disorder
James Yoo Wake Forest University Health Sciences Phase 1 Not yet recruiting 10
Gary Steinberg Stanford University Phase 1 Recruiting 30
Crystal Mackall Stanford University Phase 1 Recruiting 54
  • B cell cancers
  • Leukemia
  • Leukemia, Acute Myeloid (AML)
Maria Grazia Roncarolo Stanford University Phase 1 Recruiting 22
Joseph Wu Stanford University Phase 1 Recruiting 18
  • IPEX Syndrome
Rosa Bacchetta Stanford University Phase 1 Recruiting 36
Joseph Rosenthal City of Hope, Beckman Research Institute Phase 1 Recruiting 6
  • Severe Combined Immunodeficiency, Artemis deficient (ART-SCID)
Morton Cowan University of California, San Francisco Phase 1 Recruiting 25
Pamela Contag BioEclipse Therapeutics INC. Phase 1 Recruiting 24
David Miklos Stanford University Phase 1 Recruiting 60
  • Epilepsy
Cory Nicholas Neurona Therapeutics Phase 1 Recruiting 40
  • Muscle Injury
Peter Belafsky University of California, Davis Phase 1/2 Recruiting 62
Steven Dubinett University of California, Los Angeles Phase 1 Recruiting 24
Donald Kohn University of California, Los Angeles Phase 1 Recruiting 6
William Kennedy Excision BioTherapeutics Phase 1 Recruiting 9
Everett Meyer Stanford University Phase 1 Recruiting 22
Stephen Gottschalk St. Jude Children's Research Hospital Phase 1/2 Recruiting 28
Judith Shizuru Stanford University Phase 1/2 Recruiting 40
  • Sarcoma
Theodore Nowicki University of California, Los Angeles Phase 1 Recruiting 12
Peter Stock University of California, San Francisco Phase 1/2 Recruiting 8
Mehrdad Abedi University of California, Davis Phase 1/2 Recruiting 18
Stephanie Cherqui University of California, San Diego Phase 1/2 Recruiting 6
Saul Priceman City of Hope, Beckman Research Institute Phase 1 Recruiting 39
Krystof Bankiewicz Brain Neurotherapy Bio Phase 1 Recruiting 12
  • Corneal Damage
Sophie Deng University of California, Los Angeles Phase 1 Recruiting 20
Clive Svendsen Cedars-Sinai Medical Center Phase 1 Recruiting 16
  • COVID-19
Michael Matthay University of California, San Francisco Phase 2 Recruiting 120
  • Spina Bifida
Diana Farmer University of California, Davis Phase 1 Recruiting 55
Thomas Kipps University of California, San Diego Phase 1/2 Recruiting 138
Leo Wang City of Hope, Beckman Research Institute Phase 1 Recruiting 18
Jeffrey Lawson Humacyte, Inc. Phase 3 Recruiting 240
Antoni Ribas University of California, Los Angeles Phase 1 Recruiting 12
  • Leukemia, Acute Myeloid (AML)
Joseph Woodard Immune-Onc Therapeutics Phase 1 Recruiting 119
Anthony Gringeri ImmunoCellular Therapeutics Phase 3 Suspended 414
Pierre Caudrelier ExCellThera Inc. Phase 1 Withdrawn N/A
Icon for XLSX export